ROCKWELL MEDICAL, INC. Accrued Marketing Costs, Current
ROCKWELL MEDICAL, INC. (RMTI) had Accrued Marketing Costs, Current of $100.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Notes › Accrued Liabilities, Current
us-gaap:AccruedMarketingCostsCurrent · last filed 2020-11-09
- 2020-09-30: Accrued Marketing Costs, Current $100.00K.
- 2020-06-30: Accrued Marketing Costs, Current $191.80K.
- 2020-03-31: Accrued Marketing Costs, Current $129.94K.
- 2019-12-31: Accrued Marketing Costs, Current $61.00K; Accrued Marketing Costs, Current as first filed $61.16K.
| Period end | Accrued Marketing Costs, Current | Accrued Marketing Costs, Current as first filed |
|---|---|---|
| 2020-09-30 | $100.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $191.80K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $129.94K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $61.00K 10-Q · filed 2020-11-09 | $61.16K 10-K · filed 2020-03-17 |
| 2019-09-30 | $206.65K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $236.79K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $771.66K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $5.00K 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |